Genetic markers for predicting responsiveness to combination therapy

摘要: The invention provides compositions and methods for determining the likelihood of successful treatment with an effective amount anti-VEGF antibody or equivalent thereof, in combination anti-EGFR and, some aspects a topoisomerase inhibitor. comprise identity gene interest patient sample correlating patient's genotype predictive response. Patients identified as responsive are then treated appropriate therapy.